United States · FDA National Drug Code directory
Cambia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13913-012_b9a3d927-3dc3-4860-ac3b-3dd20df47dd6
- Product NDC
- 13913-012
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- diclofenac potassium
- Labeler
- Assertio Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160310
- Source listing expiry
- 20261231
Source-listed ingredients
- DICLOFENAC POTASSIUM — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 PACKET in 1 CARTON (13913-012-02) / 1 POWDER, FOR SOLUTION in 1 PACKET · 13913-012-02
- 9 PACKET in 1 CARTON (13913-012-03) / 1 POWDER, FOR SOLUTION in 1 PACKET (13913-012-01) · 13913-012-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →